Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 41
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
Appendix A
Promise and Problems: Hib, Pneumococcal, and Meningococcal Vaccines in the Developing World
September 12–13, 1994
Foundry Building, Room 2004
1055 Thomas Jefferson Street, NW
Washington, D.C.
Room 2004
FINAL AGENDA
Day 1
8:30
Continental Breakfast
9:00
Welcome and Introduction
Caroline Hall, Steering Committee Chair
9:10
Overview
Floyd Denny, University of North Carolina
OCR for page 42
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
9:30
Determining Vaccine Need
Moderator: Samuel Katz, Steering Committee Member
Epidemiologic Data Gaps and Their Relevance to Vaccine Studies
Mark Steinhoff, Johns Hopkins University
The Situation in Nigeria and the United Arab Emirates
Catherine Oyejide, College of Medicine, Ibadan, Nigeria
Serotype Surprise: The Case of Haemophilus influenzae in Egypt
Mona Assad, VACSERA, Cairo, Egypt
The Global Burden of N. menigitidis-Caused Meningitis
Jay Wenger, Centers for Disease Control and Prevention
10:30
Break
10:45
Discussion
11:45
Lunch
12:45
Overcoming Technologic Barriers
Moderator: Emil Gotschlich, Rockefeller University
Pneumococcal Conjugate Vaccines: Status and Prospects
John La Montagne, National Institutes of Health
The Limits of Conjugate Technology
Philip Russell, Children’s Vaccine Initiative
The Common-Antigen Approach to Vaccine Development
David Briles, University of Alabama
1:30
Discussion
2:30
Break
2:45
A Meningococcal B Vaccine for Children
Wendell Zollinger, Walter Reed Army Institute of Research
OCR for page 43
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
One Approach to Constructing a Meningococcal A/B/C Vaccine
Carl Frasch, Food and Drug Administration
3:15
Discussion
4:00
Break
4:15
Summary and Synthesis: Day 1
Moderators
4:45
Adjourn
Day 2
8:30
Continental Breakfast
9:00
Proving Vaccine Efficacy: The Challenge of Developing-Country Field Trials
Moderator: George Siber, Massachusetts Department of Health
Pneumonia Diagnostics: The Achilles Heel of ARI Epidemiology
Claire Broome, Centers for Disease Control and Prevention
The Case-Control Method and Other Alternative Design Strategies
Helena Makela, National Public Health Institute, Helsinki, Finland
Report of a Post-Licensure Hib Efficacy Trial in Chile
Myron Levine, University of Maryland
9:45
Discussion
10:45
Break
11:00
The Public-/Private-Sector Interface
Moderator: William Hubbard, Steering Committee Member
An Industry Perspective
Peter Paradiso/Frank Malinoski, Lederle-Praxis Biologicals
OCR for page 44
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
A Biotech Perspective
Dale Spriggs, Virus Research Institute
A Government Perspective
George Curlin, National Institutes of Health
11:45
Discussion
12:30
Lunch
1:15
Introducing an Effective Vaccine
Moderator: Donald Shepard, Brandeis University
The Cost-Effectiveness of ARI Vaccines
Benjamin Schwartz, Centers for Disease Control and Prevention
The Purchase and Cost of New EPI Vaccines
Maria Costales, Ministry of Health, Philippines
Financing the use of Conjugate Hib Vaccine in Brazil
Otavio Oliva, SIREVA, Rio de Janiero, Brazil
2:00
Break
2:15
Facilitating Vaccine Production Capability
George Siber, Massachusetts Department of Health
The Importance of Infrastructure and National Commitment:
Lessons from the Polio Experience
Ciro de Quadros, Steering Committee Member
2:45
Discussion
3:45
Break
4:00
Summary and Synthesis: Day 2
Moderators
4:30
Closing Comments
Caroline Hall, Steering Committee Chair
4:45
Adjourn
OCR for page 45
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
WORKSHOP SPEAKERS
Mona Asaad, M.D., Acting Director, The Egyptian Organization for Biological and Vaccine Production (VACSERA)
David Briles, Ph.D., Professor, Division of Microbiology, University of Alabama at Birmingham, Birmingham, AL
Claire Broome, M.D., Associate Director for Science, Centers for Disease Control and Prevention, Atlanta, GA
Maria Otelia Costales, Officer in Charge, Maternal and Child Health Service, Department of Health, Manila, Philippines
George Curlin, M.D., Deputy Director, Division of Microbiology and Infectious Disease, National Institute of Allergy, and Infectious Diseases, National Institutes of Health, Bethesda, MD
Floyd Denny, M.D., Professor of Pediatrics, Division of Community Pediatrics, University of North Carolina, Chapel Hill, NC
Ciro de Quadros, M.D, M.P.H., (IOM Steering Committee Member) Senior Advisor on Immunization, Pan American Health Organization, Washington, DC
Carl Frasch, Ph.D., Chief, Bacterial Polysaccharides Laboratory Division of Bacterial Products, Food and Drug Administration, Rockville, MD
Emil C. Gotschlich, M.D., Professor and Head, Bacterial, Pathogenesis and Immunology Laboratory, Rockefeller University, New York, NY
Caroline Breese Hall, M.D. (IOM Steering Committee Chair) Professor of Pediatrics and Medicine in Infectious Disease, University of Rochester, Rochester, NY
William N. Hubbard, Jr., M.D. (IOM Steering Committee Member) Hickory Corners, MI
Samuel L. Katz, M.D. (IOM Steering Committee Member), Wilburt C. Davison Professor Department of Pediatrics, Duke University Medical Center, Durham, N.C.
John La Montagne, Ph.D., Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
Myron M. Levine, M.D., D.T.P.H., Professor and Director, Center for Vaccine Development, University of Maryland, Baltimore, MD
Helena Makela, M.D., Ph.D., Director, Division of Infectious Diseases, National Public Health Institute, Helsinki, Finland
Frank J. Malinoski, M.D., Ph.D., Director, Clinical Research, Lederle-Praxis Biologicals, West Henrietta, NY
Otavio P. de Oliva, M.D., M.P.H., Coordinator Regional do SIREVA, Rio de Janeiro, Brazil
Dr. Catherine Oyejide, Department of Public Health and Occupational Medicine, United Arab Emirates University, United Arab Emirates
OCR for page 46
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
Peter Paradiso, Ph.D., Senior Director of Scientific Affairs, Lederle-Praxis Biologicals, West Henrietta, NY
Philip Russell, M.D., Special Advisor to the CVI, Center for Immunization Research, Johns Hopkins University, Baltimore, MD
Benjamin Schwartz, M.D., Chief, Childhood and Vaccine-Preventable Diseases, Epidemiology Section, Centers for Disease Control and Prevention, Atlanta, GA
Donald S. Shephard, Ph.D., Institute for Health Policy, Brandeis University, Waltham, MA
George Siber, M.D., Director, Biologics Laboratory, Massachusetts Department of Health, Jamaica Plain, MA
Dale Spriggs, Ph.D., Director, Clinical Research and Development, Virus Research Institute, Cambridge, MA
Mark Steinhoff, M.D., Associate Professor, Center for Immunization Research, Department of International Health, Johns Hopkins University, Baltimore, MD
Jay Wenger, M.D., Chief, Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA
Wendell Zollinger, Ph.D., Research Biologist, Department of Bacterial Diseases, Walter Reed Army Institute of Research, Washington, DC
WORKSHOP PARTICIPANTS
Judith R. Bale, Ph.D., Program Officer, Board on Science and Technology for International Development, Washington, DC
Kenneth Bart, M.D., Associate Director for Medical and Scientific Affairs, Office of International Health, U.S. Public Health Service, Rockville, MD
Alfred Bartlett, M.D., M.P.H., Acting Chief, Child Survival Division, Office of Health and Nutrition, Agency for International Development, Washington, DC
Ruth Brenner, M.D., Senior Staff Fellow, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD
Robert Clay, M.P.H., Acting Deputy Director, Office of Health and Nutrition, Agency for International Development, Washington, DC
John Clemens, M.D., Chief, Epidemiology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD
Jose Luis Di Fabio, Advisor on Vaccines, Pan American Health Organization, Washington, DC
Gerald W. Fischer, M.D., President, Virion, Rockville, MD
James Froeschle, M.D., Director, Clinical Research, Connaught Laboratories, Swiftwater, PA
OCR for page 47
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
Joan Fusco, North American Vaccine Inc., Beltsville, MD
Bruce G. Gellin, M.D., Assistant Professor, Department of International Health, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD
Dan Granoff, M.D., Executive Director, Clinical Research, The Biocine Company, Emeryville, CA
William Hausdorff, Ph.D., Project Officer, Children’s Vaccine Initiative Project, Agency for International Development, Office of Health and Nutrition, Washington, DC
Carole Heilman, Ph.D., Chief, Respiratory Diseases Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
Akira Homma, Ph.D., Regional Advisor on Biologics, Pan American Health Organization, Washington, DC
David L. Klein, Ph.D., Bacterial Respiratory Disease Program Officer, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
Kaimi Lin, M.D., Medical Research Officer, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD
Sharon Mates, Ph.D., President, North American Vaccine Inc., Beltsville, MD
Paul M. Mendelman, Merck Research Laboratories, West Point, PA
Molly Mort, Ph.D., AAAS Fellow, Office of Health and Nutrition, Agency for International Development, Washington, DC
Trudy Murphy, M.D., Associate Professor of Pediatrics, University of Texas, Southwestern Medical Center/Dallas, Dallas, TX
David Oot, M.P.H., Director, Office of Health and Nutrition, Agency for International Development, Washington, DC
Jan T. Poolman, M.D., Head, Laboratory of Vaccine Development and Immune Mechanisms, National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands
Regina Rabinovich, M.D., Assistant Director, Division of Microbiology and Infectious Disease, National Institute of Allergy and Infectious Diseases, Rockville, MD
Malla Rao, Visiting Scientist, National Institute of Child Health and Human Development, National Institutes of Health, Rockville, MD
Anthony Robbins, M.D., Office of the Assistant Secretary for Health, National Vaccine Program Office, Rockville, MD
John B. Robbins, M.D., Chief, Laboratory of Development and Molecular Immunology, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD
Murray Trostle, Dr.P.H., Public Health Advisor, Office of Health and Nutrition, Agency for International Development, Washington, DC
OCR for page 48
The Children’s Vaccine Initiative: Continuing Activities: A Summary of Two Workshops Held September 12–13 and October 25–26, 1994
Ronnie Waldman, M.D., M.P.H., Deputy Director/Technical, BASICS, Agency for International Development, Washington, DC
Joel I. Ward, M.D., Chief, Pediatric Infectious Diseases, Harbor-University of California/LA, Torrance, CA
Roy Widdus, Ph.D., Office of the Assistant Secretary for Health, National Vaccine Program Office, Rockville, MD
James Young, Ph.D., Vice President, Research and Development, MedImmune, Gaithersburg, MD
Paul Zeitz, D.O., M.P.H., Child Survival Fellow, Agency for International Development, Office of Health and Nutrition, Washington, DC
Beatrice Zurita, London School of Hygiene and Tropical Medicine, University of London, London, England
Staff
Greg Pearson, Project Director
Dee Sutton, Administrative Assistant
Representative terms from entire chapter:
international development
